Half-year report · Q2
3154.TEDINET S100V7O6
Period2024-07-01 → 2024-12-31
Filed2025-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥259.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥681m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥900m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥895m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥114.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥112.6bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥99.8bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥95.1bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.21 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.03 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51 | 2023-07-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.93 | 2023-07-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥4.2bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 558
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2188000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.098 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1920000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.086 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1111000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.050 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1083000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.049 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 619000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.028 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 599000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.027 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 481000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.022 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 396000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.018 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 382000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.017 | |
| Number of shares held | CurrentQuarterInstant | 10973000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.493 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 22227700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 222277 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 9617 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 22238217 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 222277 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.000 | |
| Cash and deposits | Prior1YearInstant | 13641810000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 13997468000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 58045152000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 63709067000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 12741893000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 13642234000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 13611000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 11006000 | JPY |
| Accounts receivable other | Prior1YearInstant | 6420564000 | JPY |
| Accounts receivable other | CurrentQuarterInstant | 3491004000 | JPY |
| Other ca | Prior1YearInstant | 515514000 | JPY |
| Other ca | CurrentQuarterInstant | 482929000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |